FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Clinical trial NCT05395052 · TERMINATED

Trial details

NCT number: NCT05395052
Sponsor: Fate Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Colorectal Cancer Breast Cancer Ovarian Cancer Pancreatic Cancer Head and Neck Cancer GastroEsophageal Cancer

Start date: 2022-05-31
Primary completion: 2023-08-11
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.